G. Pousse et al. / Tetrahedron 65 (2009) 10617–10622
10621
to afford 2a (140 mg, 79%) as a colorless solid. Mp: 100 ꢀC (de-
137.8 (m, C), 136.4 (C), 135.3 (m, C), 134.1–134.0 (m, C), 133.3–133.2
(m, CH), 132.7–132.2 (m, CH), 131.2–131.4 (m, C), 131.0–130.8 (m, C),
130.4–130.2 (m, CH), 130.1–129.7 (m, C), 128.9–128.7 (m, 2*CH),
127.9–127.5 (m, C), 126.0–126.7 (m, 3*CH), 122.7–122.8 (m, CH),
122.5–122.6 (m, CH), 29.5–29.4 (m, CH2), 28.1 (m, CH2), 22.8–22.6
composition). [
a
]D: ꢂ209.5 (c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3)
d
(ppm) 7.20–7.13 (d, 2H, J¼8.3 Hz), 7.11–7.08 (dd, 2H, J¼8.2 Hz and
2 Hz), 2.95–2.75 (m, 4H), 2.72–2.65 (dq, 2H, J¼16.3 Hz and 4.2 Hz),
2.29 (dt, 2H, J¼16.3 Hz and 5.6 Hz), 1.86–1.75 (m, 6H), 1.62–1.52 (m,
2H). 13C NMR (100.6 MHz, CDCl3)
d
(ppm) 146.6 (C), 139.2 (C), 136.7
(m, 2*CH2). 31P NMR (162.0 MHz, CDCl3)
d (ppm) 91.8–91.2 (m, P). IR
(C), 130.3 (CH), 127.3 (C), 119.3 (CH), 29.6 (CH2), 28.3 (CH2), 22.8
(neat, cmꢂ1): 2924, 1448, 1418, 1214, 936, 862, 747, 725. HRMS calcd
(CH2), 22.7 (CH2). 31P NMR (162.0 MHz, CDCl3)
d
(ppm) 95.3. IR
for (MꢂH)ꢂ C48H37O2PS2: 739.1894 found: 739.1901.
(neat, cmꢂꢂ1): 2927, 1464, 1212, 1051, 940, 854, 715, 681. HRMS calcd
4.13. (R)-3,30-Bis-(1-naphtyl)-5,6,7,8,50,60,70,80-octahydro-
[1,10]binaphthalenyl-2,20-phosphorodithioic acid 2f
for (MꢂH) C20H20O2PS2: 387.0642 found: 387.0656.
4.9. (R)-3,30-Dibromo-5,6,7,8,50,60,70,80-octahydro-[1,10]-
binaphthalenyl-2,20-phosphorodithioic acid 2b
Prepared according to the general procedure from 7d as a col-
orless foam (46% yield). Mp: 225 ꢀC (decomposition). [
a
]D: ꢂ174.5
(c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3)
d (ppm) 7.95–7.70 (m, 4H),
Prepared according to the general procedure from 3a as color-
less foam (70% yield). Mp: 130 ꢀC (decomposition). [
a
]D: ꢂ209.1 (c
(ppm) 7.44 (s, 2H), 2.88–
2.78 (m, 4H), 2.62–2.50 (m, 2H), 2.21–2.13 (m, 2H), 1.84–1.72 (m,
6H), 1.62–1.52 (m, 2H). 13C NMR (100.6 MHz, CDCl3)
(ppm) 143.6
7.55–7.35 (m, 10H), 7.18 (s, 1H), 7.12 (s, 1H), 2.94–2.7 (m, 6H), 2.59–
1.0, CHCl3). 1H NMR (400 MHz, CDCl3)
d
2.38 (m, 2H), 1.95–1.65 (m, 8H). 13C NMR (100.6 MHz, CDCl3)
d
(ppm) 144.2–144.1 (m, C), 138.5–138.2 (m, C), 136.8–136.7 (m, C),
d
135.9–135.7 (m, C), 134.5–134.4 (m, C), 133.7–133.5 (m, CH), 133.2–
133.1 (m, CH), 132.4–132.1 (m, C), 131.5–131.2 (m, C), 129.9–129.7
(m, CH), 129.3–129.2 (m, C), 128.9–128.5 (m, 2*CH), 127.9–127.8 (m,
C), 127.2–127.0 (m, CH), 126.5–126.2 (m, CH), 126.1–125.9 (m, CH),
125.6–125.4 (m, CH), 29.8 (m, CH2), 28.5 (m, CH2), 23.1 (m, CH2),
(C), 138.3 (C), 138.0 (C), 134.2 (CH), 128.7 (C), 112.8 (C), 29.4 (CH2),
28.1 (CH2), 22.7 (CH2), 22.5 (CH2). 31P NMR (162.0 MHz, CDCl3)
d
(ppm) 92.7. IR (neat, cmꢂ1): 2931, 1417, 1220, 1012, 949, 869, 699.
HRMS calcd for (MꢂH)ꢂ C20H18Br2O2PS2: 542.8853 found:
23.0 (m, CH2). 31P NMR (162.0 MHz, CDCl3)
d (ppm) 90.9–91.4 (m,
542.8826.
P). IR (neat, cmꢂ1): 2929, 1507, 1395, 1214, 1088, 942, 886, 800, 767,
705. HRMS calcd for (MꢂH)ꢂ. C40H32O2PS2: 639.1581 found:
639.1600.
4.10. (R)-3,30-Diphenyl-5,6,7,8,50,60,70,80-octahydro-
[1,10]binaphthalenyl-2,20-phosphorodithioic acid 2c
Prepared according to the general procedure from 7a as color-
4.14. 2-((4-Methoxyphenylamino) (4-nitrophenyl)methyl)-
cyclohexanone 11
less foam (82% yield). Mp: 170 ꢀC (decomposition). [
a]D: ꢂ226.5 (c
1.0, CHCl3). 1H NMR (400 MHz, CDCl3)
d (ppm) 7.61–7.56 (m, 4H),
To a cold solution (0 ꢀC) of 13 (51 mg, 0.2 mmol, 1 equiv) and
catalyst 2c (5.4 mg, 0.01 mmol, 5 mol %) in 2.5 mL of toluene was
added cyclohexanone (196 mg, 2 mmol, 10 equiv). The reaction was
stirred at 0 ꢀC during 3 days. The crude mixture (anti/syn 70/30 by
NMR) was concentrated and purified by flash chromatography
(cyclohexane/EtOAc, 80:20) to afford 14 as a colorless solid (65 mg,
92%). Enantiomeric excess was determined using Daicel AD-H
chiral HPLC (1 mL minꢂ1, n-heptane 75%, 12.5% MeOH, 12.5% EtOH,
20 ꢀC) to be 63% for the major anti diastereoisomer. Analytical data
was found to be identical as reported previously.14
7.44–7.38 (m, 4H), 7.37–7.32 (m, 2H), 2.98–2.91 (m, 4H), 2.78–2.68
(m, 2H), 2.45–2.38 (m, 2H), 1.91–1.80 (m, 6H), 1.74–1.69(m, 2H). 13C
NMR (100.6 MHz, CDCl3) d (ppm) 143.3 (C),138.1 (C),137.7 (C),136.5
(C), 132.6 (C), 131.5 (CH), 130.2 (CH), 129.9 (C), 128.6 (CH), 127.7
(CH), 29.7 (CH2), 28.2 (CH2), 23.0 (CH2), 22.9 (CH2). 31P NMR
(162.0 MHz, CDCl3)
d
(ppm) 91.3. IR (neat, cmꢂ1): 2925, 1601, 1444,
1409, 1207, 944, 862, 767, 696. HRMS calcd for (MꢂH)ꢂ
C32H28O2PS2: 539.1268 found: 539.1259.
4.11. (R)-3,30-Bis-(3,5-bis-trifluoromethyl-phenyl)-
5,6,7,8,50,60,70,80-octahydro-[1,10]binaphthalenyl-2,20-
phosphorodithioic acid 2d
Acknowledgements
Prepared according to the general procedure from 7c as a col-
We gratefully acknowledge Glaxo-Smith-Kline and CNRS for
orless foam (71% yield). Mp: 140 ꢀC (decomposition). [
a
]D: ꢂ166.8
´
a fellowship to GP, ANR ‘Mesorcat’ (program CP2D), Region Basse-
(c 1.0, CHCl3). 1H NMR (400 MHz, CDCl3)
d (ppm) 8.03 (s, 4H), 7.88
Normandie, Re´gion Haute-Normandie (re´seau CRUNCH) for a fel-
lowship to AD and the European Union (FEDER funding) for fi-
nancial supports.
(s, 2H), 7.29 (s, 2H), 2.98–2.92 (m, 4H), 2.80–2.68 (m, 2H), 2.51–2.40
(m, 2H), 1.97–1.84 (m, 6H), 1.80–1.68 (m, 2H). 13C NMR (100.6 MHz,
CDCl3)
d (ppm) 143.2 (C), 140.2 (C), 139.6 (C), 137.5 (C), 132.1 (C),
131.7 (C), 131.3 (CH), 130.4 (CH), 129.8 (C), 128.5 (C), 125.1 (C), 122.4
Supplementary data
(C), 121.5 (CH), 29.6 (CH2), 28.3 (CH2), 22.8 (CH2), 22.6 (CH2). 31P
NMR (162.0 MHz, CDCl3)
d
1108, 957, 892, 705, 681. HRMS calcd for (MꢂH)ꢂ C32H24F2O2PS2:
d
(ppm) 91.1. 19F NMR (235.3 MHz, CDCl3)
Supplementary data associated with this article (NMR spectra of
new compounds) can be found in the online version, at doi:10.1016/
(ppm) ꢂ62.7. IR (neat, cmꢂ1): 2937, 1620, 1460, 1388, 1275, 1179,
811.0764 found: 811.0750.
References and notes
4.12. (R)-3,30-Bis-(phenanthryl)-5,6,7,8,50,60,70,80-octahydro-
[1,10]binaphthalenyl-2,20-phosphorodithioic acid 2e
1. (a) Uraguchi, D.; Terada, M. J. Am. Chem. Soc. 2004, 126, 5356–5357; (b)
Akiyama, T.; Itoh, J.; Yokota, K.; Fuchibe, K. Angew. Chem., Int. Ed. 2004, 43,
1566–1568.
2. (a) For reviews see: Akiyama, T. Chem. Rev. 2007, 107, 5744–5758; (b) Terada, M.
Chem. Commun. 2008, 4097–4112; For more recent literature see: (c) Rueping,
M.; Antonchick, A. P. Angew. Chem., Int. Ed. 2008, 47, 5836–5838; (d) Naka-
shima, D.; Yamamoto, H. J. Am. Chem. Soc. 2006, 128, 9626–9627; (e) Sickert, M.;
Schneider, C. Angew. Chem., Int. Ed. 2008, 3631–3634; (f) Terada, M.; Soga, K.;
Momiyama, N. Angew. Chem., Int. Ed. 2008, 47, 4122–4125; (g) Cheng, X.;
Goddard, R.; Buth, G.; List, B. Angew. Chem., Int. Ed. 2008, 47, 5079–5081; (h)
Prepared according to the general procedure from 7f as a col-
orless foam (54% yield). Mp: 232 ꢀC (decomposition). [
a
]D: ꢂ73.5 (c
0.5, CHCl3). 1H NMR (400 MHz, CDCl3)
d (ppm) 8.78–8.68 (m, 4H),
8.18–8.10 (m, 1H), 7.92–7.82 (m, 4H), 7.70–7.48 (m, 9H), 7.38–7.28
(m, 2H), 3.06–2.86 (m, 6H), 2.70–2.58 (m, 2H), 2.05–1.82 (m, 8H).
13C NMR (100.6 MHz, CDCl3)
d (ppm) 144.1–143.9 (m, C), 138.2 (C),